OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The antibody response of haematological malignancies to COVID-19 infection and vaccination
Nicole A. Seebacher
British Journal of Cancer (2022) Vol. 126, Iss. 5, pp. 691-692
Open Access | Times Cited: 11
Nicole A. Seebacher
British Journal of Cancer (2022) Vol. 126, Iss. 5, pp. 691-692
Open Access | Times Cited: 11
Showing 11 citing articles:
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 7-16
Open Access | Times Cited: 15
Harry Alexopoulos, Ioannis P. Trougakos, Meletios Α. Dimopoulos, et al.
European Journal of Internal Medicine (2022) Vol. 107, pp. 7-16
Open Access | Times Cited: 15
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies
Michael A. Thompson, Sigrun Hallmeyer, Veronica Fitzpatrick, et al.
Journal of patient-centered research and reviews (2022) Vol. 9, Iss. 3, pp. 149-157
Open Access | Times Cited: 11
Michael A. Thompson, Sigrun Hallmeyer, Veronica Fitzpatrick, et al.
Journal of patient-centered research and reviews (2022) Vol. 9, Iss. 3, pp. 149-157
Open Access | Times Cited: 11
Antibody response and intra‐host viral evolution after plasma therapy in COVID ‐19 patients pre‐exposed or not to B‐cell‐depleting agents
David Gachoud, Trestan Pillonel, Γεράσιμος Τσιλιμιδός, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 4, pp. 549-559
Open Access | Times Cited: 11
David Gachoud, Trestan Pillonel, Γεράσιμος Τσιλιμιδός, et al.
British Journal of Haematology (2022) Vol. 199, Iss. 4, pp. 549-559
Open Access | Times Cited: 11
Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era
Ioannis Ntanasis‐Stathopoulos, Charalampos Filippatos, Maria Gavriatopoulou, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 123-123
Open Access | Times Cited: 4
Ioannis Ntanasis‐Stathopoulos, Charalampos Filippatos, Maria Gavriatopoulou, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 123-123
Open Access | Times Cited: 4
A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery
Sopisa Benjakul, Aina Karen Anthi, Anette Kolderup, et al.
PNAS Nexus (2023) Vol. 2, Iss. 12
Open Access | Times Cited: 4
Sopisa Benjakul, Aina Karen Anthi, Anette Kolderup, et al.
PNAS Nexus (2023) Vol. 2, Iss. 12
Open Access | Times Cited: 4
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer
Melanie Powis, Rinku Sutradhar, Aditi Patrikar, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 115, Iss. 2, pp. 146-154
Open Access | Times Cited: 6
Melanie Powis, Rinku Sutradhar, Aditi Patrikar, et al.
JNCI Journal of the National Cancer Institute (2022) Vol. 115, Iss. 2, pp. 146-154
Open Access | Times Cited: 6
Patient and health practitioner views and experiences of a cancer trial before and during COVID-19: qualitative study
Frances Sherratt, Peter Fisher, A. McL Mathieson, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Frances Sherratt, Peter Fisher, A. McL Mathieson, et al.
Trials (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Current therapies for chronic lymphocytic leukemia: risk and prophylaxis strategies for secondary/opportunistic infections
Lucia Diella, Davide Fiore Bavaro, Giacomo Loseto, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 4, pp. 267-276
Closed Access | Times Cited: 2
Lucia Diella, Davide Fiore Bavaro, Giacomo Loseto, et al.
Expert Review of Hematology (2023) Vol. 16, Iss. 4, pp. 267-276
Closed Access | Times Cited: 2
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients
Danilo De Novellis, Veronica Folliero, Valentina Giudice, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4943-4953
Open Access | Times Cited: 1
Danilo De Novellis, Veronica Folliero, Valentina Giudice, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4943-4953
Open Access | Times Cited: 1
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agents
David Gachoud, Trestan Pillonel, Tsilimidos Gerasimos, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
David Gachoud, Trestan Pillonel, Tsilimidos Gerasimos, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Patient and Health Practitioner Views and Experiences of a Cancer Trial Before and During COVID-19: Qualitative Study
Frances Sherratt, Peter Fisher, A. McL Mathieson, et al.
Research Square (Research Square) (2022)
Open Access
Frances Sherratt, Peter Fisher, A. McL Mathieson, et al.
Research Square (Research Square) (2022)
Open Access
